PMID: 10950058

Ockenga J, Stuhrmann M, Ballmann M, Teich N, Keim V, Dork T, Manns MP
Mutations of the cystic fibrosis gene, but not cationic trypsinogen gene, are associated with recurrent or chronic idiopathic pancreatitis.
Am J Gastroenterol. 2000 Aug;95(8):2061-7., [PubMed]
Sentences
No. Mutations Sentence Comment
8 ABCC7 p.Tyr1092*
X
ABCC7 p.Tyr1092* 10950058:8:99
status: NEW
view ABCC7 p.Tyr1092* details
ABCC7 p.Ile336Lys
X
ABCC7 p.Ile336Lys 10950058:8:92
status: NEW
view ABCC7 p.Ile336Lys details
Three patients (15.0%) had a cystic fibrosis (CF) mutation on one chromosome (⌬F508, I336K, Y1092X), which is known to cause phenotypical severe cystic fibrosis. Login to comment
10 ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 10950058:10:54
status: NEW
view ABCC7 p.Arg75Gln details
ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 10950058:10:180
status: NEW
view ABCC7 p.Arg75Gln details
ABCC7 p.Ile336Lys
X
ABCC7 p.Ile336Lys 10950058:10:170
status: NEW
view ABCC7 p.Ile336Lys details
In addition, two possibly predisposing CFTR variants (R75Q, 1716G3A) were detected on four patients, one of these being a compound heterozygous for the missense mutation I336K and R75Q. Login to comment
11 ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 10950058:11:49
status: NEW
view ABCC7 p.Arg75Gln details
ABCC7 p.Ile336Lys
X
ABCC7 p.Ile336Lys 10950058:11:33
status: NEW
view ABCC7 p.Ile336Lys details
No other family member (maternal I336K; paternal R75Q; sister I1336K) developed pancreatitis. Login to comment
28 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 10950058:28:99
status: NEW
view ABCC7 p.Arg117His details
To date, five mutations with varying effect on the developing of the disease have been identified (R117H, N21I, K23R, A16V, D22G (8-12). Login to comment
53 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 10950058:53:182
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 10950058:53:239
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 10950058:53:148
status: NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 10950058:53:197
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 10950058:53:216
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 10950058:53:274
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 10950058:53:141
status: NEW
view ABCC7 p.Arg347Pro details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 10950058:53:189
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 10950058:53:175
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 10950058:53:246
status: NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Ser1251Asn
X
ABCC7 p.Ser1251Asn 10950058:53:281
status: NEW
view ABCC7 p.Ser1251Asn details
ABCC7 p.Glu60*
X
ABCC7 p.Glu60* 10950058:53:135
status: NEW
view ABCC7 p.Glu60* details
Using the ARMS technology (elucigene CF20, Zeneca Diagnostics, Oxfordshire, UK) all samples were tested additionally for the mutations E60X, R347P, A455E, 1078delT, 2183AA3G, G542X, G551D, N1303K, W1282X, 1717-1G3A, R553X, 621ϩ1G3T, R117H, R1162X, 3849ϩ10kbC3T, R334W, S1251N, and 3659delC. Login to comment
54 ABCC7 p.Arg347His
X
ABCC7 p.Arg347His 10950058:54:86
status: NEW
view ABCC7 p.Arg347His details
ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 10950058:54:73
status: NEW
view ABCC7 p.Arg75Gln details
ABCC7 p.Tyr1092*
X
ABCC7 p.Tyr1092* 10950058:54:150
status: NEW
view ABCC7 p.Tyr1092* details
ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 10950058:54:170
status: NEW
view ABCC7 p.Asp1152His details
ABCC7 p.Ile336Lys
X
ABCC7 p.Ile336Lys 10950058:54:79
status: NEW
view ABCC7 p.Ile336Lys details
Finally, we tested all samples for the presence of mutations or variants R75Q, I336K, R347H, IVS8-5T (5T allele), 1716G3A, 2143delT, 2789ϩ5G3A, Y1092X, 3272-26A3G, D1152H, and CFTRdel2,3 (21kb) by PCR and restriction enzyme digestion with the respective enzymes (for mutation references, see http://www.genet. Login to comment
77 ABCC7 p.Tyr1092*
X
ABCC7 p.Tyr1092* 10950058:77:101
status: NEW
view ABCC7 p.Tyr1092* details
ABCC7 p.Ile336Lys
X
ABCC7 p.Ile336Lys 10950058:77:94
status: NEW
view ABCC7 p.Ile336Lys details
RESULTS CFTR Screening In 3/20 (15.0%, CI: 5.2-36.0%) patients a CFTR mutation (⌬F508, I336K, Y1092X) known to cause a phenotypical severe clinical course of cystic fibrosis was detected (p Ͻ 0.05 compared to expected frequency of 4%). Login to comment
78 ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 10950058:78:68
status: NEW
view ABCC7 p.Arg75Gln details
ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 10950058:78:148
status: NEW
view ABCC7 p.Arg75Gln details
ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 10950058:78:189
status: NEW
view ABCC7 p.Arg75Gln details
ABCC7 p.Ile336Lys
X
ABCC7 p.Ile336Lys 10950058:78:138
status: NEW
view ABCC7 p.Ile336Lys details
In four patients two potentially predisposing variants, 1716G3A and R75Q, were also present, one of these being compound heterozygous for I336K and R75Q, whereas the other two carried only R75Q or 1716G3A. Login to comment
89 ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 10950058:89:245
status: NEW
view ABCC7 p.Arg75Gln details
ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 10950058:89:338
status: NEW
view ABCC7 p.Arg75Gln details
ABCC7 p.Tyr1092*
X
ABCC7 p.Tyr1092* 10950058:89:287
status: NEW
view ABCC7 p.Tyr1092* details
ABCC7 p.Ile336Lys
X
ABCC7 p.Ile336Lys 10950058:89:239
status: NEW
view ABCC7 p.Ile336Lys details
Characteristics of the Study Population Patient Gender CFTR Genotype PolyT Genotype Age at Study, Yr Age at Onset of Disease, Yr Inclusion Criteria Pseudomonas Antibody* Exocrine Insufficiency† Morphological Changes‡ S. K. F I336K/R75Q 7T/7T 34 26 CP 2.44 Yes Mild M. T. M Y1092X/wt 7T/7T 34 30 CP 1.06 Yes Moderate K. M. M R75Q/wt 7T/7T 24 19 RAP 0.46 No Mild L. A. F 1716G3A/wt 7T/7T 27 26 RAP 0.45 No Normal C. B. F ⌬F508/wt 7T/9T 40 38 CP 0.84 No Mild W. O. M 1716G3A/wt 7T/7T 31 29 RAP 0.86 No Normal L. M. F wt/wt 5T/7T 37 27 CP 1.25 Yes Moderate H. K. F wt/wt 7T/7T 27 20 CP 0.84 Yes Mild K. A. M wt/wt 7T/7T 24 19 CP 0.57 Yes Mild H. K. M wt/wt 7T/7T 23 19 CP 0.58 Yes Severe E. H. M wt/wt 7T/7T 25 20 RAP 1.36 No Normal M. K. F wt/wt 7T/7T 35 30 CP 0.55 No Moderate W. S. M wt/wt 7T/7T 19 19 RAP 0.58 No Normal L. D. F wt/wt 7T/7T 33 30 CP 1.07 Yes Severe S. Login to comment
104 ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 10950058:104:170
status: NEW
view ABCC7 p.Arg75Gln details
ABCC7 p.Ile336Lys
X
ABCC7 p.Ile336Lys 10950058:104:179
status: NEW
view ABCC7 p.Ile336Lys details
Family Study of CFTR In the compound heterozygous patient S.K., we investigated the parents and the sister of this patient for the presence of the missense substitutions R75Q and I336K. Login to comment
106 ABCC7 p.Ile336Lys
X
ABCC7 p.Ile336Lys 10950058:106:37
status: NEW
view ABCC7 p.Ile336Lys details
DNA analysis determined the mutation I336K in patient S.K. and her sister; the mutation had been inherited from their mother. Login to comment
107 ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 10950058:107:41
status: NEW
view ABCC7 p.Arg75Gln details
On the other hand, missense substitution R75Q was found on the paternal CFTR allele of the patient S.K., which was different from the paternal CFTR allele of her sister (Fig. Login to comment
110 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 10950058:110:29
status: NEW
view ABCC7 p.Arg117His details
Neither the known mutations (R117H, N21I, K23R, A16V, D22G) nor any new mutations were present. Login to comment
117 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 10950058:117:72
status: NEW
view ABCC7 p.Arg117His details
Increased trypsin activity may either be achieved by reduced autolysis (R117H), acid stability (N21I), facilitated activation of trypsinogen to trypsin (D22G, K23R), or intracellular transport defects (A16V). Login to comment
124 ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 10950058:124:368
status: NEW
view ABCC7 p.Arg75Gln details
ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 10950058:124:432
status: NEW
view ABCC7 p.Arg75Gln details
ABCC7 p.Tyr1092*
X
ABCC7 p.Tyr1092* 10950058:124:404
status: NEW
view ABCC7 p.Tyr1092* details
ABCC7 p.Ile336Lys
X
ABCC7 p.Ile336Lys 10950058:124:362
status: NEW
view ABCC7 p.Ile336Lys details
Results of Sweat Test, Intestinal Current Measurement Test, and Anamnestic Features of Patients With Idiopathic Recurrent Acute or Chronic Pancreatic Disease and an Abnormal CFTR Allele Patient CFTR Genotype PolyT Genotype Sweat Chloride (mmol/L) Intestinal Current Measurement (␮A/cm2 )* Anamnestic Features Known to be Associated With Atypical CF S. K. I336K/R75Q 7T/7T 26 50 Nasal polyps M. T. Y1092X/wt 7T/7T 42 27 K. M. R75Q/wt 7T/7T 61 31 L. A. Login to comment
136 ABCC7 p.Ile336Lys
X
ABCC7 p.Ile336Lys 10950058:136:127
status: NEW
view ABCC7 p.Ile336Lys details
Restriction enzyme analysis of exon 7 with SspI detected an atypical band at 410 bp (panel A), suggesting a heterozygosity for I336K. Login to comment
137 ABCC7 p.Ile336Lys
X
ABCC7 p.Ile336Lys 10950058:137:147
status: NEW
view ABCC7 p.Ile336Lys details
Further direct sequence analysis (panel B) showed an exchange of thymidin (T) to adenine (A) at position 1139, confirming the presence of mutation I336K (37). Login to comment
143 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 10950058:143:104
status: NEW
view ABCC7 p.Arg117His details
This is supported by recent evidence that patients with chronic alcoholic pancreatitis do not carry the R117H and N21I mutations (23). Login to comment
151 ABCC7 p.Tyr1092*
X
ABCC7 p.Tyr1092* 10950058:151:49
status: NEW
view ABCC7 p.Tyr1092* details
ABCC7 p.Ile336Lys
X
ABCC7 p.Ile336Lys 10950058:151:39
status: NEW
view ABCC7 p.Ile336Lys details
In addition, we detected the mutations I336K and Y1092X, which have not been described before, in patients with idiopathic pancreatitis. Login to comment
155 ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 10950058:155:26
status: NEW
view ABCC7 p.Arg75Gln details
ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 10950058:155:125
status: NEW
view ABCC7 p.Arg75Gln details
ABCC7 p.Ile336Lys
X
ABCC7 p.Ile336Lys 10950058:155:130
status: NEW
view ABCC7 p.Ile336Lys details
The missense substitution R75Q was found in two unrelated pancreatitis patients (10%), one of them compound heterozygous for R75Q/I336K. Login to comment
156 ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 10950058:156:39
status: NEW
view ABCC7 p.Arg75Gln details
In a previous study, we had identified R75Q in two CBAVD patients and in 4% of random control individuals from the German population (17). Login to comment
157 ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 10950058:157:19
status: NEW
view ABCC7 p.Arg75Gln details
In another report, R75Q has been detected in six CF patients, five of them showing very mild symptoms of the disease (30). Login to comment
158 ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 10950058:158:89
status: NEW
view ABCC7 p.Arg75Gln details
ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 10950058:158:133
status: NEW
view ABCC7 p.Arg75Gln details
ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 10950058:158:227
status: NEW
view ABCC7 p.Arg75Gln details
Although another patient with severe CF was found to carry a second-site mutation on the R75Q allele, no further mutation apart from R75Q could be discovered in the five mildly affected patients. It has been suggested that the R75Q missense substitution represents a borderline CF mutation, which may need additional environmental factors to trigger the disease (30). Login to comment
159 ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 10950058:159:88
status: NEW
view ABCC7 p.Arg75Gln details
Further studies of larger cohorts are required to clarify the role and relevance of the R75Q substitution in the etiology of cystic fibrosis and pancreatic disease. Login to comment
182 ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 10950058:182:75
status: NEW
view ABCC7 p.Arg75Gln details
ABCC7 p.Ile336Lys
X
ABCC7 p.Ile336Lys 10950058:182:184
status: NEW
view ABCC7 p.Ile336Lys details
The fact that the paternal CFTR allele from our patient S.K. harboring the R75Q substitution is different from the paternal CFTR allele of her sister-who, like her mother, carries the I336K mutation without having developed pancreatitis-supports this theory. Login to comment